Pharvaris NV (PHVS) Company Profile & Statistics

Pharvaris NV
PHVS
(Nasdaq - US)
N/A
24.72
+0.13 (+0.53%)
in:usd•As of: May 01, 2024 15:59 UTC -4
Open
23.50
High
25.12
Low
23.25

About Pharvaris NV

CEO

Berndt Modig

Headquarters

emmy noetherweg 2

leiden, p7 , netherlands

Auditor

PricewaterhouseCoopers Accountants N.V.

Employees

Share Holders

N/A

Website

https://pharvaris.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Pharvaris N.V. is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative therapies, including novel, small molecule bradykinin-B2-receptor antagonists for the treatment of hereditary angioedema and other bradykinin-B2-receptor-mediated indications. Pharvaris N.V. is based in ZUG, Switzerland.

Pharvaris NV Statistics

Valuation Measures

Market Capitalization ²	N/A
Enterprise Value	N/A
Enterprise Value/EBITDA (ttm)	N/A
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	4.75
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-47.92%
Return on Invested Capital (ttm)	-54.00%
Return on Assets (ttm)	-44.45%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-104.61M
Net Income Avi to Common (ttm)	-109.18M
Diluted EPS (ttm)	-2.84

Share Statistics

Beta (5Y Monthly)	-3.12
52-Week Change	167.24%
S&P500 52-Week Change	23.73%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	52.29M
Dividend Yield	0.00%
Float ⁴	0.00
% Held by Insiders	N/A
% Held by Institutions	0.00%

Balance Sheet

Total Cash (mrq)	423.43M
Total Cash Per Share (mrq)	8.10
Total Debt (mrq)	258.60K
Total Debt/Equity (mrq)	0.06%
Current Ratio (mrq)	27.25%
Quick Ratio (mrq)	27.25%
Book Value Per Share (mrq)	7.95

Cash Flow

Operating Cash Flow Per Share (ytd)	-2.62
Free Cash Flow (ytd)	-100.80M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Pharvaris NV

Trade With A Regulated Broker